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Abstract.  Two cytoplasmic variants of the or6 integrin, 
ot6A and t~6B, have been identified previously (Hoger- 
vorst, E,  I. Kuikman,  A.  G. van Kessel, and A.  Son- 
nenberg.  1991. Eur. J. Biochem.  199:425-433; Cooper, 
H. M.,  R.  N.  Tamura,  and V.  Quaranta.  1991. J. 
Cell Biol.  115:843-850).  Using synthetic peptides, 
containing  sequences of their cytoplasmic domains, 
we have produced mAbs specific for either of the vari- 
ants.  These antibodies reacted with a variety of differ- 
ent epithelial tissues. In some tissues (e.g.,  salivary 
gland) both variants could be detected while in others 
only one of the variants was found (e.g.,  u6A in epi- 
dermis and ot6B in kidney). Among nonepithelial  cells 
and tissues, perineural  fibroblasts and Schwann cells 
in peripheral  nerves and platelets reacted with anti- 
ot6A, while microvascular endothelia reacted with 
both anti-ot6A  and anti-ot6B.  From our immunohisto- 
chemical results there is no evidence that combination 
with/31  or/34 is restricted to one of the two variants 
of or6. This was confirmed by immunoprecipitation 
studies which showed that both/31  and/34  were copre- 
cipitated by both anti-ot6A  or anti-u6B antibodies from 
cells. Also, the distribution of ot6A and t~6B subunits 
associated with/31  on cells attached to laminin  was 
similar:  both were found in focal contacts colocalizing 
with vinculin.  In contrast,  the c~6A subunit,  associated 
with/34 in cultures of a  squamous cell carcinoma 
cell line,  was found to codistribute with bullous 
pemphigoid antigen 230 in hemidesmosomal-like 
structures. 
The ot6A and a6B variants,  immunoprecipitated from 
various cell lines, exhibited slightly different electro- 
phoretic mobilities. Analysis of the antigens under re- 
ducing conditions showed that the mobility of the light 
chains,  but not of the heavy chains,  is different. In ad- 
dition,  in some cells the light chains of 0¢6A and ot6B, 
each are of two different sizes. Treatment with N-glyca- 
nase showed that these two light chain variants of ot6A 
and a6B are not due to differences in N-linked glyco- 
sylation, and may therefore represent alternative 
proteolytic products of the or6 precursor. 
We further demonstrate that t~6A, but not ot6B, is a 
major target for PMA-induced phosphorylation.  Phos- 
phorylated ot6A contained phosphoserine and a  small 
amount of phosphotyrosine.  There are also two vari- 
ants of the integrin  ce3 subunit with different cytoplas- 
mic domains, but in the cell lines examined only ct3A 
could be demonstrated by RT-PCR. The ot3A subunit 
exhibits increased phosphorylation in cells treated with 
PMA but to a lesser degree than does ot6A. Like 
ot6A, the ot3A subunit is phosphorylated both on ser- 
ine and weakly on tyrosine. Phosphorylation of the A 
but not of the B variants of the o~6 subunit may indi- 
cate different regulation mechanisms for the two sub- 
units.  Furthermore,  phosphorylation of ot subunits as 
they occur in or3 and ~6 might influence their function. 
VER  the  past  few  years,  the  number  of identified 
integrins  has considerably increased.  In addition  to 
novel ot and/3 subunits, new combinations of ot and ~/ 
subunits have been recognized (1, 16, 29). The complexity of 
the integrin  family was further increased by the discovery 
that, due to alternative  splicing, variants of ot and/3 subunits 
occur (16). The integrin ct6 subunit has been shown to com- 
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bine with either ~1 (11, 34) or ~4 (12, 19, 36). The a6/~l inte- 
grin is expressed on platelets,  lymphocytes, epithelial cells, 
and a variety of other cell types (37), and functions as a lami- 
nin  receptor (3, 35, 38, 41).  The tissue distribution  of the 
ot6/34 integrin is more restricted.  It is found in various epithe- 
lial tissues,  endothelia,  and peripheral nerves (22, 37).  In 
skin and cornea, ot6/~4 is concentrated in hemidesmosomes, 
suggesting a role in epithelial cell-basement membrane inter- 
action (18, 40, 43). It has been shown that c~6/~4  on colon car- 
cinoma cells binds to laminin (25, 26). The ligand for a6/~4 
on other cell types is not known. Keratinocytes which express 
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o~6/34 on normal mammary cells and mammary tumor cell 
lines has no detectable affinity for laminin, in contrast to 
c¢6/31 expressed on these cells (38, 41). 
The/34 subunit is a transmembrane molecule with an extra- 
cellular domain that is homologous to that of other/3 sub- 
units, but with a unique, long cytoplasmic domain of ~ol,000 
amino acids (14, 44). Furthermore, there is evidence that the 
/34 mRNA can be alternatively spliced, leading to variants 
of/34 with different cytoplasmic domains (14, 44, 49). 
Recently, we and others have shown that the or6 subunit is 
encoded by two different mRNb~s (7,  15, 50).  The two o~6 
variants, called ot6A and c~6B, have unique cytoplasmic do- 
mains of 36 and 54 amino acids, respectively. The GFFKR 
sequence, which is located immediately carboxyterminal to 
the transmembrane domain of every ot subunit cloned so far, 
is the only homologous sequence of the a6A and ~6B cyto- 
plasmic domains. PCR analysis has demonstrated that most 
carcinoma cell lines contain both ot6A and o~6B mRNAs, al- 
though the relative amounts of the two variants seem to vary 
(15). By contrast, most normal tissues appear to have mRNA 
for only one of the two or6 variants (50). 
In this report we describe the production of a6A and ot6B 
specific mAbs. By immunohistochemistry  using these mAbs 
we show that the ~6A and ot6B subunits have distinct distri- 
bution patterns. Furthermore, we provide evidence for the 
alternative usage of proteolytic cleavage sites in the precur- 
sor or6 subunit. We also show that in several carcinoma cell 
lines cz6A but not a6B  is  a  major target of phorbol  12- 
myristate 13-acetate (PMA)-induced phosphorylation. 
Materials and Methods 
Cell Lines and mAbs 
The following human cell lines were used: HBL-100, normal mammary epi- 
thelial cells; OVCAR-4,  ovarian carcinoma cells; A549, breast carcinoma 
cells; T24, bladder carcinoma ceils; Tera-2 clone 13, an embryonal carci- 
noma cell line (obtained as a gift from Dr. C.L. Mummery, Hubrecht Lab, 
Utrecht, The Netherlands); and UMSSC-22B,  squamous  cell carcinoma 
cell line (kindly provided by Dr. T.E. Carey, University of Michigan, Ann 
Arbor, Michigan). Cell lines were cultured in DME,  supplemented with 
10% FCS. The rat mAb GoH3, which is specific for the integrin ct6 subunit 
and the mouse mAb C17 against the integrin t3 subunit have been described 
previously (34, 53). The mouse mAb J143,  which recognizes the integrin 
t~3 subunit 0143) was a gift of Dr. A. Albino (20). Dr. M. Hemler kindly 
provided the mouse mAb A-1A5 against the ~  (10) and Dr. S. Kennel pro- 
vided the rat mAb 439-9B against the integrin/~4 subunit (21). Rabbit anti- 
bnilous pemphigoid antigen 230 (BPA 230) was produced by immunization 
with a fusion protein containing the earboxy-terminai part of BPA 230 (51). 
It was kindly provided by Dr. J. R. Stanley (National Institutes of Health, 
Bethesda, Maryland). 
Generation of  Hybridomas to tx6A and ~6B 
To immunize mice against the c~6A or ~6B antigens, we synthesized a 28- 
amino acid-long peptide corresponding to the COOH-terminal portion of 
the cytoplasmic domain of e~6A, KKDHYDATYHKAEIHAQPSDKERLT- 
SDA, and a 34-amino acid peptide corresponding to an internal sequence 
of the cytoplasmic domain of u6B, SRYDDSVPRYHAVRIRKEEREIKDE- 
KYIDNLEKK.  An additional cysteine residue was synthesized at the NH2 
terminus to couple the peptides to keyhole limpet hemocyanin (Sigma Chem- 
icai Co.,  St. Louis, MO.).  Both free and coupled peptides were used for 
immunization of Baib/c mice. After four immunizations the mice were sac- 
rificed for fusion.  The fusion was carried out with polyethylene glycol 
(PEG) 4000 using isolated spleen cells and Sp2/0 mouse myeloma cells at 
a ratio of 4:1. The cells were plated at 2  x  10  ~ cells/well in a 96-well tissue 
culture plate and after 1 d, selection medium (hypoxanthine/azaserine) was 
added.  10-14 d after fusion the supernatants were collected and screened 
for antibodies in an ELISA, as described below.  Selected hybridomas were 
cloned by limiting dilution and were injected into pristane-primed Balb/c 
mice for production of ascitic fluid. 
ELISA for Screening of  Hybridoma Supernatants 
Maxisorb-plates (Nunc, Roskilde,  Denmark) were coated overnight with 
100  ng peptide/well  in  PBS  at 4°C.  Plates  were  subsequently  washed 
with PBS/Tween-20 (0.05%) and incubated for  1 h  at room temperature 
with PBS/FCS  (2%) to  reduce  nonspecific binding.  After an additional 
wash the plates were incubated with hybridoma supernatant for 1 h at room 
temperature. The plates were washed three times with PBS/Tween-20 after 
which goat anti-mouse Ig conjugated to alkaline phosphatase  (Promega 
Corp., Madison, WI) was added. After incubation at room temperature for 
1 h, the plates were washed. Antibody binding was detected by incubation 
with p-nitrophenyl phosphate substrate (Sigma Chemical Co.). 
Reverse Transcription and PCR 
eDNA synthesis of total RNA or messenger RNA and amplification with 
the PCR were performed as described (15).  The primers used for the a6 
PCR were:  (a) sense primer position 2656-2675,  5'-CTAACGGAGTCT- 
CACAACTC-3',  and (b) antisense primer position 3514-3532,  5'-CGA- 
AGGTACAGTTTTAACT-Y (15), and for the o~3 PCR: (a) sense primer po- 
sition 2963-2977,  5'-ACCATCAACATGGAG-Y; and (b) antisense primer 
position  3613-3630,  5'-CTTACAACGCCGAGTC~A-3'  (48).  Amplified 
DNA was analyzed on 1.25%  agarose gels. 
Immunoprecipitation and Electrophoresis 
Adherent cells and human platelets were surface labeled with 12sI by the 
lactoperoxidase/hydrogen peroxide method as previously described (34), 
washed and solubilized in lysis buffer containing 1% (vol/vol) NP-40,  20 
mM Tris, pH 7.5, 4  mM EDTA,  100 mM NaCl,  1 mM PMSF,  10 #g/ml 
soybean trypsin inhibitor and 10 #g/rrd leupeptin. The lysates were clarified 
at 15,000 rpm and precleared by incubation with protein A-Sepharose CL- 
4B (Pharmacia LKB Biotechnology Inc., Uppsala, Sweden). After incuba- 
tion with mAbs and rabbit anti-mouse or anti-rat antibodies, immune com- 
plexes were collected with protein A-Sepharose. Treatment of the immuno- 
precipitates  with  N-glycanase  (Genzyme  Corp.,  Cambridge,  MA)  was 
performed as described (37). Immnnoprecipitated material was analyzed by 
SDS-PAGE. 
I mmunoperoxidase 
Immunoperoxidase staining of cryostat sections of various human tissues 
was carried out by an indirect procedure using HRP-conjugated second anti- 
body  (33).  Reactivity was visualized using hydrogen peroxide and 3'3'- 
diaminobenzidine  as  substrate.  The  sections  were  counterstained  with 
hematoxylin and mounted in Depex (British Drug House Chemicals, Poole, 
UK).  Control reactions were performed with Sp2/O culture medium. 
Immunofluorescent Staining of  Focal Contacts 
Glass coverslips were coated overnight at 4°C  with 20 #g/ml laminin in 
PBS. After washing with PBS, the coverslips were incubated with PBS/BSA 
(0.35 % wt/vol) to reduce nonspecific binding of cells to the glass. Cultured 
adherent OVCAR-4 cells were detached with trypsin/EDTA  and washed 
twice with serum-free culture medium containing 0.35% BSA. The cells 
were allowed to attach to the coated coverslips for 2 h at 37°C. The nonad- 
herent cells were then removed by washing the covet'slips with PBS. The 
attached cells were fixed with 1% (wt/vol) paraformaldehyde in PBS for 10 
min at room temperature, permeabilized with 0.5 % (vol/vol) Triton X-100 
in PBS for 5 min at room temperature, and then blocked by incubation in 
PBS/BSA. They were incubated for 30 min at 37°C with primary antibody, 
washed with PBS and then incubated for 30 rain at 37°C with fluorescein 
isothiocyanate coupled goat antibodies against mouse IgG (Central Labora- 
tory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, 
The Netherlands) or Texas red-coupled donkey anti-rabbit IgG (Amersham 
Corp., Buckinghamshire, UK).  The coverslips were washed, mounted in 
PBS containing 50%  glycerol and 10%  (wt/vol)  1.4 diazobicyclo-2,2,2,- 
octane (Janssen Biochemica, Beerse, Belgium) and viewed under a Zeiss 
microscope (Carl Zeiss, Inc., Thornwood, NY) equipped with epifluores- 
cence or a confocal scanning laser microscope (BioRad, Richmond, CA). 
The Journal of Cell Biology, Volume 121,  1993  180 Table L Binding of  mAbs 1AlO and 6B4 to Immobilized Peptides in ELISA 
No.  Peptide 
Reactivity  in ELISA 
1A10  6134 
a6A(28) 
47 
14 
15 
a3A(29) 
a6B(47) 
a6B(34) 
76 
4g 
74 
3O 
a3B(32) 
(C)  KKDHYDATYHKAEIHTQPSDKERLTSDA* 
NKKDHYDATYHKAEI 
TYHKAEIHTQPSDK 
HTQPSDKERLTSDA 
(C)  RTRALYEAKRQKAEMKSQPSETERLTDDY 
(C)  SRYDDSVPRYHAVRIRKEEREIKDEKYIDNLEKKQWITKWNRNESYS 
(C)  SRYDDSVPRYHAVRIRKEEREIKDEKYIDNLEKK  ° 
PRYHAVRIRKEER 
AVRIRKEEREIKDE 
EREIKDEKYIDNLE 
EKYIDNLEKKQWITK 
(C) TRYYQIMPKYHAVRIREEERYPPPGSTLPTKK 
+++ 
++ 
--  +++ 
--  +++ 
-  ± 
--  ++ 
* Peptides used for immunization. 
Immunofluorescent Staining of  Stable 
Anchoring Contacts 
For stable anchoring contact (SAC) ~ staining, coverslips were used that 
were not coated, but only washed with alcohol. After plating UMSSC-22B 
cells on these coverslips, they were cultured for 2 d in DME, supplemented 
with 10% FCS. Ceils were fixed as above and incubated with primary anti- 
body, followed by appropriate secondary antibodies coupled with fluores- 
cein dyes. BODIPY-conjugated goat anti-rabbit IgG and Texas  red-con- 
jugated goat anti-rat IgG  were purchased from Molecular Probes, Inc. 
(Eugene, OR) and Texas red-conjugated sheep anti-mouse IgG was from 
Amersham Corp. 
~2P-labeling and PMA Treatment 
Cell  cultures  (25  cm  z,  80%  confluency)  were  washed  twice  with 
phosphate-free MEM (Flow Laboratories, [rvine, UK), incubated in the 
same medium for 10-20 min at 37"C, and labeled for 2 h at 37°C with 
0.5 mCi/ml [32Plorthophosphate (carrier free; Amersham). PMA (Sigma 
Chemical Co.) was added for 15 rain at the end of the labeling period at 
a  final concentration of 20 ng/ml. Labeled cells were washed twice with 
cold PBS and lysed in lysis buffer containing 2 mM sodium orthovanadate, 
10 mM sodium fluoride, and 10 mM sodium phosphate, pH 7.5. The lysate 
was then used for immunoprecipitation analysis. 
Phosphoamino Acid Analysis 
Bands were cut out of the fixed and autoradiographed SDS-gels and pro- 
teins were boiled for 10 min in 50 mM NH4HCO3,  0.1%  SDS and 5% 
B-mercaptoethanol and extracted for 3 h at 37"C. The extracted proteins 
were precipitated by TCA (15%) and ribonuclease (20 #g/ml) was used as 
carrier protein. The precipitates were washed twice with ice-cold acetone 
and, after drying, dissolved in 75/~I 6 N HCI. The proteins were hydrotyzed 
for 1 h at 110°C. The amino acid mixture was resolved by electrophoresis 
on thin layer cellulose plates in two dimensions at pH  1.9 and pH 3.5 in 
the presence of unlabeled phosphoamino acids (5). The plates were dried 
and the positions of the unlabeled phosphoamino acids were visualized by 
staining with 0.15%  (wt/vol) ninhydrin in acetone. Labeled phosphoamino 
acids were identified after autoradiography. 
Results 
Production of mAbs to a6A and a6B 
Hybridomas were produced from spleen cells of mice im- 
munized with peptides comprising the main portion of the 
1. Abbreviations used in this paper: RT-PCR, reverse transcription-PCR; 
SAC, stable anchoring contact. 
cytoplasmic domains of the a6A and ct6B variants, which 
were coupled to keyhole limpet hemocyanin. Two mAbs, 
1A10 and 6B4, were selected because they reacted in ELISA 
with either o~6A or ot6B, respectively. These two antibodies 
were classified as IgG1. 
Fine Mapping of the Epitopes Recognized by 
1A10 and 6B4 
To identify more precisely the epitopes recognized by the 
mAbs 1A10 and 6B4, overlapping peptides corresponding to 
regions of the cytoplasmic domains of ot6A and ot6B were 
synthesized. Furthermore ot3A and t~3B peptides of regions 
similar to those from ~6A and a6B used for immunization 
were synthesized. Table I shows the reactivity of the mAbs 
with  the  various  peptides  in  ELISA.  The  1A10 antibody 
reacted strongly with the peptide used for immunization and 
with  one of the  three  smaller peptides,  namely  the  one 
representing the 14 carboxyl-terminai amino acids of the cy- 
toplasmic domain of ottA. No reactivity was observed with 
the a3A peptide. The 6B4 mAb reacted with the 35-amino 
acid peptide used for immunization, as well as with the 48 
mer, representing the almost complete cytoplasmic domain 
of a6B. The antibody also showed reactivity with no. 74 of 
the smaller peptides and reacted very weakly with no. 48. 
The antibody did not react with the ct3B peptide. 
Expression of  mRNAs for the A  and B Variants of  =3 
and ~6 in Cell Lines 
For further characterization of the antibodies, cell lines ex- 
pressing a6A and/or ct6B were needed. To identify such cell 
lines, reverse transcription (RT)-PCR analysis of the two a6 
mRNAs as well as those for the two or3 variants was per- 
formed. PCRs were carried out on cDNAs prepared from the 
various cell lines, using c~6 and a3 primer sets covering the 
alternatively spliced regions. The results are shown in Fig. 
1.  The o~6 mRNA  in  UMSSC-1,  T24,  and a  keratinocyte 
cDNA  library was  almost exclusively for the  A  variant, 
whereas it was mainly for the B variant in Colo 320. For the 
present study we selected the following cell lines: HBL-100, 
OVCAR-4,  T24,  and  Tera-2  (which  contains  solely  ct6B 
mRNA) (13b) and A549. 
In contrast to the a6 PCR, the ct3 PCR showed only one 
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PCR. PCR was performed as described in Materials and Methods. 
cDNA was synthesized from mRNA of A375 (melanoma, lane 1 ), 
A549 (mamma carcinoma,  lane 2),  CAMA (mamma carcinoma, 
lane 3),  Colo 320 (colon carcinoma,  lane 4),  HBL-100 (normal 
mammary cells,  lane 5),  HepG2 (hepatoma,  lane 6),  OVCAR-4 
(ovarian carcinoma,  lane  7),  I24 (bladder  carcinoma,  lane  8), 
UMSSC-1 (squamous  carcinoma,  lane  9),  ZR-75 (mamma car- 
cinoma,  lane 10), and total phage DNA from human keratinocyte 
(lane 11) and human mammary gland hgtl 1 cDNA libraries (lane 
12). The results of the ct6 PCR are shown in the top panel and those 
of the c~3 PCR at the bottom.  The PCR products were separated 
on 1.25% agarose gels and stained with ethidium bromide. 
product, corresponding to the a3A mRNA, in all cell lines 
tested. This suggests that the regulation of splicing of ct 3 and 
oc6 is not coordinated. 
Specificity of the ~6A and ~6B mAbs 
When  a  lysate of '25I-surface-labeled HBL-100  cells  was 
used for immunoprecipitation with the  1A10 antibody, both 
c~6/~1 and 0t6/~4 integrins were recovered (Fig. 2). The 1AI0 
antibody also immunoprecipitated these two integrins in the 
presence of 100/zg/ml c~6B peptide, while the same concen- 
tration of ~6A peptide completely blocked this precipitation. 
Similarly,  the  immunoprecipitation of c~6/~1 and  ~6~4  by 
6B4 was blocked by the o~6B peptide. The c~6A and c~6B pep- 
Figure 2. Specificity of mAbs 
GoH3,  1AI0, and 6B4 in im- 
munoprecipitation  analysis. 
Lysates  of  surface-iodinated 
HBL-100 cells were immuno- 
precipitated  with  1AI0 (lanes 
1-3),  6134 (lanes  4-6)  or 
GoH3 (lanes  7-9) in the ab- 
sence or presence  (+) of the 
indicated peptides (100/~g/ml). 
The immunoprecipitates were 
analyzed by SDS-PAGE  on 5 % 
polyacrylamide  gels under non- 
reducing conditions. 
Figure 3.  Preclearing  analysis of proteins  recognized  by GoH3, 
1A10, and 6B4. A  t25I-labeled lysate of HBL-100 cells  was pre- 
cleared using control mAb (C17), GoH3, 1A10, 6B4, or a combina- 
tion of 1A10 and 6B4, as indicated. After two successive preclear- 
ing steps, the lysate was used for immunoprecipitations  with C17 
(lanes 1 ), GoH3 (lanes 2), 1AI0  (lanes 3) and 6134 (lanes 4). Sam- 
pies were analyzed by SDS-PAGE on a 5% polyacrylamide  gels 
under  nonreducing conditions. 
tides had no effect on the recovery of o~6/31 and ot6134 when 
the mAb GoH3 was used for immunoprecipitation.  These 
results confirm the specific reactivity of the  IA10 and 6B4 
antibodies with the ct6A and c~6B variants, respectively, and 
demonstrate that both u6A and ct6B  subunits can associate 
with ~1 or/34 (50). Fig. 2 also shows that under nonreducing 
conditions  the  o~6B band migrated slightly  faster than the 
ct6A band (see also below). 
To confirm that the integrins precipitated by the 1A10 and 
6B4 antibodies are subsets of the molecules recognized by 
the  ct6-specific  antibody  GoH3,  preclearing  experiments 
were  carried  out.  Lysates  of  HBL-100  cells  were  first 
precleared with control mAb (C17, an anti-fl3 mAb), GoH3, 
1A10, 6B4,  or a  combination of 1A10 and 6B4.  Then,  ali- 
quots were immunoprecipitated with the same panel of anti- 
bodies. After preclearing with a control mAb, the c¢6fll and 
a6/34 complexes could be readily immunoprecipitated with 
all three anti-c~6-mAbs (Fig. 3). However, after preclearing 
with GoH3, no precipitation with this antibody or with the 
a6A and a6B specific antibodies was seen.  Similar results 
were obtained when preclearing was performed using a com- 
bination of 1A10 and 6B4, although some precipitation was 
still seen with GoH3. Preclearing with  1A10 decreased the 
amount  precipitated  by  GoH3,  but  had  no  effect  on  the 
precipitation by 6B4. Conversely, preclearing with 6B4 par- 
tially decreased precipitation by GoH3, but did  not affect 
precipitation by  1A10. Thus,  the  u6  subunits  precipitated 
with GoH3 from HBL-100 cells consist of a mixture of u6A 
and o~6B variants. 
Different Forms of u6A and u6B 
Previous studies have shown that the c~6 subunit is synthe- 
sized as a  single subunit that is proteolytically cleaved into 
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ct6B variants  from HBL-100 
cells by SDS-PAGE  under non- 
reducing and reducing condi- 
tions. Lysates  of  surface-labeled 
HBL-100 cells were immuno- 
precipitated  with  1A10+6B4 
(lane 1), 6B4 (lanes 2 and 4), 
IA10 (lane 3 and 5) and GoH3 
(lane 6).  Samples were ana- 
lyzed by SDS-PAGE  on a 5 % 
polyacrylamide  gels under non- 
reducing (NR)  and reducing  (R) 
conditions. 
Figure 4. Analysis of the c~6A and c~6B  light chains from platelets, 
OVCAR-4 and HBL-100 cells. Lysates of surface-labeled platelets 
(A), OVCAR~4 and HBL-100 cells (B) were immunoprecipitated 
with GoH3 (lane 1 ), IA10 (lane 2), and 6B4 (lane 3). Immunopre- 
cipitates were untreated (-) or treated (+) with N-glycanase (see 
Materials and Methods). Samples were analyzed by SDS-PAGE  on 
a  10% polyacrylamide gel under reducing conditions. 
a heavy and a light chain, which are disulfide-bonded (36). 
The heavy chain contains the bulk of the extracellular part 
of or6, while the light chain contains the residual part of the 
extracellular domain, the transmembrane region, and the en- 
tire cytoplasmic domain (15, 49).  Furthermore, analysis of 
the or6 subunit from various cell lines by SDS-PAGE revealed 
that the light chain consists of a doublet of polypeptides of 
31 and 30 kD (37). We investigated whether these two light 
chains correspond to the o~6A and c~6B light chains or to al- 
ternatively cleaved products of a single precursor. Precipita- 
tion ofet6 by GoH3 from platelet lysates yielded a light chain 
doublet of 31 and 30 kD (Fig. 4 A, lanes 1 ). After treatment 
with N-glycanase, which removes both high-mannose and 
complex-type N-linked  sugars  (27),  the doublet remained 
detectable but the  size of the two  polypeptides that con- 
stituted the doublet was reduced to 25 and 24 kD, consistent 
with previous results (37).  Results of immunoprecipitation 
of platelet lysates with the mAb  1A10 were the same (Fig. 
4 A, lanes 2). Thus, there are two ot6A light chains, which 
were designated ct6A and a6A'. Only very small amounts of 
o~6B were precipitated by the mAb 6B4 from platelets (Fig. 
4 A, lanes 3). 
Fig. 4 B shows the analysis of immunoprecipitates of ot6A 
and ot6B from the cell lines HBL-100 and OVCAR-4.  From 
both cell lines, immunoprecipitation of a6 by GoH3 yielded 
the light chain doublet of 31 and 30 kD, whose mobility again 
shifted after N-glycanase treatment to 25 and 24 kD (Fig. 4 
B, lanes 1 ). Immunoprecipitation with the mAbs 1A10 (Fig. 
4 B, lanes 2) and 6B4 (Fig. 4 B, lanes 3) showed that the 31- 
kD band was specifically recognized by 1A10, and the 30-kD 
band by 6]34.  This is essentially different from the results 
with platelets from which the mAb  1A10 immunoprecipi- 
tated two light chains. 
From HBL-100 cells,  1A10 also immunoprecipitated two 
light chains, but one was much more strongly labeled than 
the other. The weakest band migrated slightly faster than the 
prominent ot6A band and it almost comigrated with the a6B 
band. It seems likely that this band corresponds to the c~6~ 
light chain  precipitated  from platelets.  A  similar  smaller 
polypeptide was observed in the precipitation by 6B4 and 
this we named et6B'. 
The observation that the u6B light chains migrated faster 
than the c~6A light chains was unexpected because it did not 
correlate with the predicted differences in size of the two or6 
light chain variants, the cr6B light chain being 18 amino acids 
longer than the et6A light chain (7,  15). 
As seen in Fig. 5, SDS-PAGE analysis of t~6A and ot6B un- 
der nonreducing conditions also indicated that the intact ot6B 
subunit migrated faster than the intact o~6A subunit.  How- 
ever, upon reduction the heavy chains of ot6A and ot6B co- 
migrated at the 120-kD position. This suggests that the light 
chains are responsible for the difference in mobility of the 
intact subunits. 
PMA Induces Phosphorylation of the ct6A But Not the 
ot6B Subunit 
Shaw  et al.  have recently reported that  in  mouse macro- 
phages the t~6 subunit becomes phosphorylated when these 
ceils are treated with PMA (30). To investigate whether both 
c~6 variants can be phosphorylated, cell lines which express 
primarily ot6A or ot6B, or both were labeled with p2P]or- 
thophosphate and treated with PMA or not.  Lysates from 
these cells were then immunoprecipitated with the 1A10 and 
Figure 6. Analysis of c~6 inte- 
grins  from  1"24 and  Tera-2 
cells.  125I-labeled cell lysates 
were immunoprecipitated  with 
GoH3 (lanes 1),  1A10 (lanes 
2), 6134 (lanes 3), and A-1A5 
(lanes  4).  The  precipitates 
were analyzed by SDS-PAGE 
on a 10% polyacrylamide gel 
under reducing conditions. 
Hogervorst  et al. Characterization of the a6A and a6B Subunits  183 Figure 7. Analysis of the effect of PMA on the phosphorylation of a6. Cell cultures ofT24 (,4), Tera-2 (B), HBL-100 (C), and A549 (D) 
were metabolically labeled with [32P]orthophosphate for 2 h and incubated with (+) or without (-) PMA (20 ng/ml) for 15 min. Cell 
lysates were immunoprecipitated  with J143 (lanes 1 and 6), GoH3 (lanes 2 and 7), 1A10 (lanes 3 and 8), 6B4 (lanes 4 and 9) and A-1A5 
(lanes 5 and 10). Samples were analyzed by SDS-PAGE on a 10% polyacrylamide  gel under reducing conditions. E shows  the immunopre- 
cipitation analysis of ~I-labeled  A549 cells with GoH3 (lane H),  1A10 (lane 12), 6B4 (lane 13), and A-IA5 (lane 14). 
6B4, as well as with the GoH3 and the A-1A5 (anti-/31) anti- 
bodies.  A  mAb against the c~3 subunit,  which is  consti- 
tutively phosphorylated  (20),  was  included as  a  positive 
control. 
Immunoprecipitation analysis of ~25I-labeled 124 cells re- 
vealed that they predominantly express ct6A (Fig. 6), which 
is only weakly phosphorylated (Fig.  7 A, lanes 2  and 5). 
However, after the cells were treated with PMA for 15 min, 
the intensity of the atA band increased significantly (Fig. 7 
A, lanes 7 and 10). Some phosphorylation is also seen in a 
band migrating slightly faster than the c~6A band which is 
probably due to phosphorylation of a6/¢ and not of t~6B; the 
a6g band migrates to practically the same position as o~6B. 
Interestingly, the mAb  1A10 (Fig. 7 A, lanes 3 and 8) did 
not precipitate the phoshorylated form of  ot6A. This suggests 
that  phosphorylation of the  cytoplasmic domain of ot6A 
affects recognition of  its epitope by the mAb. Phosphorylated 
light chains of ot 3  were  detected in both or3  and/31  im- 
munoprecipitates (Fig.  7 A,  lanes 1  and 5,  respectively). 
Like the or6 light chain, the or3 light chain runs as a closely 
spaced doublet (35 and 34 kD) and its phosphorylation is in- 
creased after treatment with PMA (Fig. 7 A, lanes 6 and 10). 
Tera-2 cells only express a6B as is shown in immunopre- 
cipitation of ~zSI-labeled cells by the GoH3 and 6B4 anti- 
bodies (Fig.  6).  The u6B light chain in these cells is not 
phosphorylated, and in contrast to what happens with a6A//¢ 
in 124 cells, phosphorylation was not induced by treatment 
with  PMA.  No  precipitation  with  either  GoH3,  6B4  or 
A-1A5 was seen at the position of phosphorylated ot6B light 
chains (Fig. 7 B, lanes 7, 9, and 10). Tera-2 cells do not ex- 
press or3 (13b) and consequently, no phosphorylated ct3 light 
chains were detected. 
Because phosphorylation of cytoplasmic domains of inte- 
grin subunits might be inefficient in Tern-2 cells, we have 
also tested two other cell lines HBL-IO0 and A549, which 
express both tx6A and c~6B. The presence of ot6A in these 
cells allows us to judge the efficiency of phosphorylation by 
PMA.  Because on SDS-PAGE,  as already discussed,  the 
~6B light chain migrates slightly faster than ot6A, we can 
distinguish between phosphorylated ot6A and ot6B in im- 
munoprecipitations by GoH3. 
Analysis  of  HBL-100  cells  which  have  almost  equal 
amounts of o~6A and ot6B (Fig. 1) again showed that txtA but 
not ot6B was phosphorylated by PMA treatment (Fig. 7 C, 
lane 7). A minor phosphorylated band seen just below the 
ot6A band  probably  represents  ot6A', mAb  1A10 did not 
precipitate phosphorylated a6A, which confirms the results 
obtained with the 124 cell line (Fig. 7 C, lane 8). Immuno- 
precipitation with the 61M antibody was negative (Fig. 7 C, 
lanes 4 and 9), confirming that phosphorylation oft~6B can- 
not be detected. In addition to the ~6 variants, the HBL-100 
cell line expresses the a3/31 integrin (38) and as seen in Fig. 
7 C, the light chain doublet of this subunit was weakly phos- 
phorylated in untreated cells (Fig. 7 C, lanes I and 5). PMA 
treatment (Fig. 7 C, lanes 6 and 10) increased the amount 
of phosphorylated o~3 light chains. 
Fig. 7 D shows the analysis of the A549 cell line. This cell 
line contains more o~6B than o~6A (Fig. 7 E). As observed 
in 124 and HBL-100 cells the cttA light chains became phos- 
phorylated by PMA treatment (Fig. 7 E, lanes 7and 10), but 
again there was no evidence for phosphorylation of ~x6B. 
Similar results were obtained with the OVCAR-4 and Colo- 
320 cell lines (not shown). Thus, in several cell lines, o~tA 
but not a6B could be shown to become phosphorylated by 
treatment with PMA. 
Phosphoamino acid analysis was performed to determine 
which amino acids were phosphorylated in the cytoplasmic 
domains of the o~6A and ot3A subunits. Phosphorylated t~tA 
and ot3A proteins, precipitated from PMA-treated 124 ceils, 
were isolated from SDS-gel, partially hydrolyzed with acid 
and analyzed by thin-layer electrophoresis. Fig. 8 shows that 
both o~6A and c~3A were predominantly phosphorylated on 
serine residues. A low level of tyrosine phosphorylation was 
also observed for both proteins, but no threonine phosphory- 
lation was apparant. Phosphoamino acid analysis of the/34 
subunit revealed that serine was the major phosphorylated 
amino acid, but phosphorylated tyrosine and threonine were 
also detectable. 
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subunits. T24 ceils were labeled with [32P]orthophosphate,  treated 
with PMA for 15 min and lysed. The lysate was used for precipita- 
tion of utA and c~3A light chains and the t4 subunit. After extrac- 
tion, these polypeptides were subjected to acid hydrolysis and fur- 
ther analyzed using thin layer electrophoresis. (A and B) analysis 
of the cttA light chains; (Cand D) analysis of the c~3A light chains; 
(E and F) analysis of the t4 subunits. A, C, and E show the nin- 
hydrin staining of the phosphoamino acid standards and B, D, and 
F show the autoradiograms. 
Distribution of  c~6A and ,6B Variants in Focal 
Contacts and Stable Anchoring Contacts 
The  ot6/31 integrin  localizes  in  focal  contacts  when  OV- 
CAR-4 cells attach to and spread on laminin (41).  To see 
whether they contain both c~6A and c~6B subunits, OVCAR-4 
cells were grown on laminin-coated coverslips and stained 
in double immunofluoresence with anti-vinculin to visualize 
focal contacts and with the mAbs IA10 or 6B4. Staining of 
OVCAR-4 by GoH3 (Fig. 9 a) or A-1A5 (Fig. 9 d) showed 
distinct localization patterns, at the periphery of the cells. 
Staining with anti-vinculin confirms that these elements are 
focal contacts (Fig. 9, e and h). The staining patterns with 
the mAbs  1A10 and 6134 were similar (Fig. 9, b and c) and 
there was complete codistribution with anti-vinculin (Fig. 9, 
f  and g).  The staining reactions by these mAbs,  however, 
were weaker. These results indicate that both t~6 variants can 
localize in focal contacts. 
In cultured keratinocytes adhering to secreted extracellu- 
lar matrix, the ot6fl4 integrin localized in SACs  These SACs 
resemble hemidesmosomes in skin and are associated with 
BPA 230 (6, 42). Because keratinocytes only express the A 
variant of a6, we assume that these adhesion structures will 
be stained by 1A10. To find support for this assumption, we 
examined the distribution of ot6Afl4 in SACs of UMSSC-22B 
cells,  human  squamous  carcinoma cells,  that  form SACs 
upon adherence to secreted extracellular matrix. As shown 
in Fig.  10 staining with 1A10 produced a brush-like pattern 
that codistributed with SACs  as revealed by staining  with 
anti-BPA 230 antiserum. The staining patterns produced by 
mAb GoH3, directed to or6 that reacts with both its variants, 
and mAb 439-9B, against 84 were similar to that by 1A10. 
This shows that the integrin in SACs is ottAfl4. No staining 
was seen with 6B4 which is consistent with the finding that 
these cells express only low levels of t~6B as was detected 
by immunoprecipitation and RT-PCR (not shown).  As ex- 
pected,  when  UMSSC-22B  cells  were  stained  with  anti- 
vinculin, a focal distribution is observed which shows  little 
colocalization with SACs as stained by anti-or6 (not shown). 
Tissue Distribution of  ~6A and ~6B 
Immunoperoxidase staining  of frozen tissue  sections with 
the 1A10 and 6B4 antibodies revealed that the ~6A and o~6B 
subunits have distinct patterns of distribution (Table II). In 
skin,  1A10 stained the basement membrane zone (BMZ) of 
the epidermis (Fig.  11 b).  Staining was also seen in sweat 
glands (Fig. 12 b), peripheral nerves (Fig.  13 b), sebaceous 
glands  and  some blood vessels present in  the dermis.  In 
sweat glands, the reactivity of 1A10 was confined to myoepi- 
thelial cells;  lumenal cells were not stained.  In peripheral 
nerves, reactivity was prominent in perineurium and in (my- 
elinated)  Schwann cells,  whereas other cells in the tissue 
showed  only  weak  reactivity.  The  6]34  antibody  reacted 
weakly with sweat glands (Fig.  12 c) and sebaceous glands 
and blood vessels, but not with epidermis (Fig.  11 c) or pe- 
ripheral nerves (Fig. 13 c). In the mammary gland, myoepi- 
thelial  cells  of ducts  and  alveoli  in  the  mammary  gland 
stained with 1A10 (Fig.  11 e), but not with 6B4 (Fig.  11 f). 
In contrast, kidney tubules reacted with 6B4 (Fig.  12f) but 
not with 1A10 (Fig.  12 e). Neither 1A10 or 6B4 antibodies 
reacted with glomeruli.  Furthermore, 6B4 stained epithe- 
lium of colonic crypts (Fig. 12 i). These cells reacted weakly 
with 1A10 (Fig.  12 h). Finally, in salivary gland, both 1A10 
and  6B4  stained the BMZ  of ducts  and  acini  (Fig.  11,  h 
and i). 
With two exceptions, all structures which were stained by 
either 1A10 or 6B4 were also reactive with the GoH3 anti- 
bodies (Figs. 11-13, a, d, and g). The exceptions are smooth 
muscle cells (muscularis of the intestine and smooth muscle 
cells in large vessel walls) and striated muscle cells, which 
displayed strong and weak reactivity with 1A10, respectively, 
but did not react with GoH3 (not shown). 
Discussion 
In  this  paper,  we  describe  the  characterization of mAbs 
directed against two variants of ~6,  ottA, and o~6B. Using 
peptides that represent the major portion of the cytoplasmic 
domains of o~6A and ot6B for immunization,  we prepared 
several mAbs reacting with either o~6A or o~6B peptides. Im- 
munohistochemistry and immunoprecipitation studies per- 
formed with these mAbs, revealed that the tissue expression 
of the ottA and o~6B variants is different and that their struc- 
tures are heterogenous. 
Most tissues appeared to contain either the t~6A and ot6B 
Hogervorst  et al.  Characterization of the ct6A and ct6B Subunits  185 Figure 9. Localization of c~6 variants in focal contacts.  OVCAR-4 cells were allowed to adhere and spread on mouse laminin-coated  glass 
coverslips  for 2 h, fixed with paraformaldehyde,  permeabilized  with Triton X-100 and stained  with mAbs GoH3 to c~6 (A), tA10 to c~6A 
(B), 6B4 to ~6B (C), and A-1A5 to 131 (D), and then labeled  with FITC-conjugated goat anti-mouse antibody.  E-H shows the staining 
of vinculin  performed on the same cells using a rabbit  polyclonal  antibody to vinculin  as primary antibody and a Texas red-conjugated 
donkey anti-rabbit secondary antibody. 
subunit.  In some tissues,  e.g.,  salivary gland and intestine, 
both variants are expressed, the reactivity with anti-c~6B be- 
ing stronger than with anti-c~6A.  There was no correlation 
between the presence in tissues of a6A or o~6B and the pres- 
ence of/31 or f14. Platelets and renal tubuli,  which contain 
/31  but  not/34,  express  only  a6A  and  c~6B, respectively, 
which suggests that the two variants of or6 can combine with 
/31.  However,  because  the  affinity  of o~6  for  /34  is  much 
greater than that for/31  (12,  21),  it can be assumed that in 
tissues which express both/31 and/34 the two variants of c~6 
will mainly combine with 134. 
There is good agreement between our results and those of 
the RT-PCR assays described by Tamura et al.  (50).  These 
authors found that kidney only contains transcripts for a6B, 
whereas transcripts for both ~6A and ot6B were found in sali- 
vary gland and intestine.  These results correspond with the 
reactions  we found with  the variant  specific mAbs.  Apart 
from the fact that our studies confirm and extend the distri- 
Figure 10. Localization of the A variant of c~6 in SACs. UMSCC-22B cells were plated on alcohol-washed  coverslips and cultured  for 2 d. 
They were then fixed with paraformaldehyde,  permeabilized with Triton X-100 and stained  with mAbs GoH3 to c¢6 (A),  1A10 to c~6A 
(B), 6B4 to ot6B (C), and 439-9B to j34 (D), and then labeled  with Texas red-conjugated secondary antibodies.  E-H shows the staining 
of BPA 230 performed on the same cells using rabbit anti-BPA 230 and BODIPY-conjugated goat anti-rabbit as a secondary antibody. 
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Tissue  1A t0  6134  GoH3 
Skin 
Epidermis  +  +  -  +  + 
Sweat gland  +  +  +  +  + 
Sebaceous gland  +  +  + 
Mammary  gland 
Aveoli  +  +  -  +  + 
Ducts  +  +  -  +  + 
Salivary gland 
Acini  +  +  +  +  + 
Ducts  +  +  +  +  + 
Large  intestine 
Crypts  +  +  +  + 
Muscularis  +  +  -  - 
Kidney 
Glorneruli  -  -  + 
Proximal  tubuli  -  +  +  + 
Distal  tubuli  -  +  +  + 
Peripheral  nerve 
Perineurium  +  +  -  +  + 
Schwann  cells  +  +  -  +  + 
Vascular system 
Capillaries 
Endothelial  cells  +  +  + 
Arterioles and veins 
Smooth  muscle cells  +  +  -  - 
Endothelial  cells  -  - 
Striated muscle  +  -  - 
(+ +) very strong; (+)  strong; (+) weak; and (-)  no staining. 
bution pattern as obtained by RT-PCR, it also provides infor- 
mation about the expression of the ot6A and ot6B variants at 
the single-cell level. For example, it is clear from the im- 
munohistochemical but not from the RT-PCR analysis, that 
both variants are expressed in the same ductal and acinar 
cells of the salivary gland. 
In spite of the good correlation between the results of our 
antibodies and those obtained by RT-PCR, it should be kept 
in mind that the anti-o~6A  antibody, 1A10, does not react with 
phosphorylated t~6A. Therefore, a negative result obtained 
with this antibody does not conclusively mean that atA is 
absent. 
In  epidermis  o~6/$4 has  been  localized in  hemidesmo- 
somes, suggesting that it might be essential in the formation 
of these structures  (18, 40,  43).  ot6B4 is also present in 
perineural fibroblasts and Schwann cells of  peripheral nerves 
and the question arises whether in these cells it is also local- 
ized in hemidesmosomes. We could not define hemidesmo- 
somes in these ceils by electron microscopy nor could we de- 
tect the hemidesmosomal associated protein BPA 230 (42) 
in them. This is consistent with the absence of these struc- 
tures in perineural fibroblasts and Schwann cells. Perhaps it 
is interesting to mention that another component of hemides- 
mosomes, the 500-kD  HD1  protein (13) could be demon- 
strated  both  in  Schwann  cells  and  perineural  fibroblasts 
(Daams, H, and A. Sonnenberg, unpublished data). Thus, 
the question remains whether the absence of hemidesmo- 
somes could be due to a different role of the two variants of 
c¢6 in their assembly, This is unlikely because our results 
show that in both epidermis and peripheral nerves ~6 is of 
the A variant. Alternatively, epidermis and peripheral nerves 
might express different forms of the cytoplasmic domain of 
/34. In any case, the results show that the presence of ot6AB4 
by itself is insufficient to ensure hemidesmosome formation. 
All  tissues  which  reacted  with either  1AI0  or 6134 also 
reacted with mAb GoHD. The only two exceptions were stri- 
ated and smooth muscle cells, which were stained by 1A10, 
but not by GoH3 and other c~6 specific mAbs (Daams, H., 
and A. Sonnenberg, unpublished data). This indicates that 
the  c~6A mAb  shows  crossreactivity,  possibly  with  a 
subunlts, like a3 and a7 which closely resemble a6. How- 
ever,  1A10 does not react with ~DA peptide and does not im- 
munoprecipitate a3131 from cell lysates. Recently, the eDNA 
for the a7 subunit, which is expressed in muscle cells, has 
been cloned (32). There is no homology  between the protein 
sequence of the cytoplasmic domains of a7 and ot6A. In- 
stead, there is partial homology  between t~7 and the uDB and 
u6B cytoplasmic domains. Therefore, the reactivity of IA10 
with smooth and striated muscle cells cannot be explained 
by crossreactivity with ot6-1ike ot molecules. Immunoprecip- 
itation analysis of surface-labeled, cultured smooth muscle 
cells with  1A10 did not result in the identification of the 
antigen recognized by this mAb. The exact nature of the epi- 
tope recognized by 1A10 in muscle cells remains therefore 
unknown. 
We have previously reported on the structural complexity 
of the ~6 subunit (37, 39). Variations in the glycosylation of 
the heavy and light chains of c~6 were found in platelets and 
various cell lines. Furthermore, we have shown that the ~6 
light chains, which contain the entire cytoplasmic domain of 
the c~6 subunit, had different polypeptide backbones, which 
run as a doublet in SDS-gels under reducing conditions. Two 
explanations were suggested: (a) alternative splicing of the 
c¢6 mRNA and/or (b) differences in proteolytic processing 
of the c~6 precursor. Our present studies produced evidence 
for both options. First, immunoprecipitation with the variant 
specific mAbs showed that, in most cell lines, the doublet 
contains both a6A and a6B light chains; the upper band of 
the doublet represents the ot6A and the lower band the ot6B 
light chain. The relative intensity of the two bands in most 
instances  reflects the  relative  amounts of a6A  and  ot6B 
mRNA as detected by RT-PCR  analysis (Fig.  1) (15). 
Second, both anti-or6 (GoHD) and anti-ct6A (1A10) mAbs 
immunoprecipitated a light chain doublet (o~6A and ot6A') 
from platelets. Two distinct light chains remained after treat- 
ment with N-glycanase, indicating that differences in length 
of the polypeptide backbones may be responsible for the 
different electrophoretic mobilities of t~6A and t~6A'. Since 
we have not observed alternative splicing of u6 mRNA in ad- 
dition to that responsible for the generation of ot6A and a6B, 
we hypothesize that the two variants of the et6A light chain 
result from alternative proteolytic processing. We also de- 
tected a doublet of a6B light chains, ot6B and ot6B', before 
and after N-glycanase treatment, which may similarly repre- 
sent alternative proteolytic products of t~6B. 
Besides ~6, several other a  subunits of the integrin family 
are endoproteolytically  cleaved into a heavy and a light chain 
(2, 4, 24, 28, 46-48).  Analysis of the NH2 terminus of the 
ctv and or4 light chains showed that the cleavage  site is lo- 
cated after two consecutive basic amino acids (45, 52). Re- 
Hogervorst et al. Characterization of the ~6A and ¢x6B Subunits  187 Figure 11. Immunoperoxidase staining of human tissue sections with mAbs GoH3 (a, d, and g),  1A10 (b, e, and h) and 6134 (c, f, and 
i). Skin sections (a, b, and c) showing  linear GoH3 and 1A10 reactivity of the basement membrane zone. mAb 6B4 did not stain. Sections 
of mammary gland (d, e, and  f) showing  reactivity of GoH3 and 1A10 in myoepithelial  cells. Salivary gland sections (g, h, and i) showing 
acini and ducts stained with all three antibodies. 
cently, Kolodziej et al. (23) determined the cleavage site in 
GPIIb, using site-directed mutagenesis. They found that the 
basic amino acids, lysine and arginine, at positions 858-859 
were essential for cleavage. 
The o~6 sequence contains four dibasic sequences in the re- 
gion  corresponding  to  that  in  which  GPIIb  and  t~v  are 
cleaved (15, 49).  Two of these sequences are consecutive 
(876-877 and 878-879)  and the others are located at posi- 
tions 890-891 and 898-899.  The sequence, located at posi- 
tions 890-891,  is not conserved in chicken ct6 cDNA (8) or 
in other cleaved a subunits and is therefore unique for human 
ct6. Because of the homology between the a  subunits, we as- 
sume that the ~6 precursor might be cleaved after arginine 
879 or lysine 899. Analysis of ot6A and et6B precipitates on 
SDS-PAGE under reducing conditions showed that the heavy 
chains of o~6A and oL6B comigrated as a single band. There- 
fore, we suspect that there is a primary cleavage site, located 
after position 879, and a second, alternatively used, site after 
position 899. We also observed that o~3A light chains consist 
of a doublet. Taking into account the strong homology be- 
tween ~3 and or6, we assume that ~3 is also alternatively 
cleaved at similar positions as or6. 
Although the light chain of t~6B is 18 amino acids longer 
than that of t~6A, the former migrated faster both before and 
after N-glycanase treatment. We suspect that the posttransla- 
tional cleavage products of the two variants do not differ, but 
that their migration is influenced by conformational differ- 
ences of their cytoplasmic domains. 
The question is whether the cytoplasmic variants of et6, 
ot6A, and ot6B, and their different cleavage products influ- 
ence the function of the ct6/~l integrin. From what is known 
about other integrins, cleavage of the ct subunits apparently 
does not influence the affinity for their ligands. Kolodziej et 
al.  (23)  showed that mutations induced in  GPIIb  cDNA 
which resulted in the production of uncleaved mature GPIIb, 
did not alter the ability of the complex to bind to fibrinogen 
(23). The capacity of or4 containing integrins to bind to their 
ligands was also independent of whether or not they were 
cleaved (52). 
The following observations also do not indicate a func- 
tional difference between a6A and ot6B. We have previously 
found that platelets and Tera-2  cells adhere to laminin and 
that this adhesion could be blocked by the rnAb GoH3 (3, 
35).  In this study, we have shown that platelets have almost 
exclusively ot6A/~l, while Tera-2 cells only express ot6BB1. 
Furthermore, both variants of c~6 colocalized with vinculin 
in focal adhesions when OVCAR-4 cells adhered to laminin, 
suggesting that they both can interact with this ligand. It also 
suggests that at least with respect to  interaction with the 
cytoskeleton,  ot6A/~l and  o~6B/~l integrins  do  not differ. 
However,  the conditions for the interaction of the two vari- 
ants with their ligand and the cytoskeleton remain to be es- 
The Journal of Ceil Biology, Volume 121,  1993  188 Figure 12. Immunopemxidase staining of human tissue sections with mAbs GoH3 (a, d, and g),  1A10 (b, e, and h) and 61M (c, f, and 
i). Sections of sweat glands (a, b, and c) showing staining of myoepithelial  cells with GoH3 and 1A10. A weak staining was observed 
with 6134. Sections of kidney tissue (d, e, and  f) showing  reactivity of GoH3 and 6134 with the tubules, mAb IA10 did not stain. Sections 
of colonic crypts (g, h, and i) showing staining of the epithelial layer with GoH3 and 6B4. The same epithelial cells are weakly stained 
by 1A10. 
tablished. Because ~6B is not detectably phosphorylated, 
phosphorylation cannot be a major condition for the interac- 
tion  of  the  tx6BB1 integrin  with  its  ligand  and/or  the 
cytoskeleton. On the other hand, phosphorylation of ot6ABl 
might be required for its interaction either with both the 
ligand and cytoskeleton or only the latter.  In fact,  PMA 
induced-phospborylation of tx6Bl in macrophages has been 
associated with the binding of this  integrin to  the actin- 
containing cytoskeleton and with an increased affinity for 
laminin (receptor activation) (30). Also the ot6B1 integrin on 
T-cells is activated by PMA (31). Platelets, however, can ad- 
here directly to taminln without being activated with PMA 
or other stimuli (17, 35). Because the 1A10 mAb, not recog- 
nizing phosphorylated u6A,  reacted almost as strongly as 
GoI-I3 with c~6AB1 on platelets, both in immunoprecipitation 
analysis (Fig. 4) and in immunohistochemistry (not shown), 
the majority of the ot6A subunits apparently are not phos- 
phorylated. This was further confirmed by metabolic label- 
ing  of  platelets  with  [32P]orthophosphate  (not  shown). 
Thus, while in some cells (e.g., macrophages) phosphoryla- 
tion of the t~6A subunit might be essential for their interac- 
tion with laminin, this appears not to be the case in platelets. 
Furthermore, in epidermis, ~6AB4 is localized in hemides- 
mosomes of basal keratinocytes and interaction of this inte- 
grin with both ligand and cytoskeleton is presumed to occur 
(18, 40, 43). Basal keratinocytes react with the 1A10 mAb, 
as strongly as GoH3. Therefore, also in keratinocytes, phos- 
phorylation  of c~6A may not be essential for either ligand rec- 
ognition or cytoskeletal interactions by a6AB4. This conclu- 
sion is further supported by the observation that with the 
mAb 1A10 the ot6A subunit is localized in the SAC structures 
of cultured  UMSSC-22B  cells.  However,  in  these  ceils 
ot6AB4 is likely to interact with the keratin filament system 
rather than with the actin-containing cytoskeleton  as in mac- 
rophages.  Finally, there is increasing evidence for the in- 
volvement of integrins in signal transduction (16) and it is 
therefore possible that the two variants transduce signals in 
a  different way in response  to interaction with the same 
ligand.  All these points  as well as the question whether 
different cleavages  also influence the intracellular function 
for ot6B1 are subjects of further investigation. 
In conclusion, we have described the production and char- 
acterization of  anti-ot6A and anti-ct6B rnAbs. We have shown 
that the expression of the or6 variants is tissue-specific and 
that both forms may be subject to alternative endoproteolytic 
cleavage. Finally, we provide evidence that o~6A but not et6B 
is a major target of PMA-induced phosphorylation. 
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